ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS - Spain 

Ranking results:

Past rankings:

2020
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:900-1000
Total Number of Projects:> 1000
2019
Criterium:Position:
Overall Score:600-700
Total Project Funding per Partner:500-600
Total Number of Projects:800-900
2018
Criterium:Position:
Overall Score:> 1000
Total Project Funding per Partner:500-600
Total Number of Projects:> 1000
Networking Rank (Reputation):> 1000
2016
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000
2015
Criterium:Position:
Overall Score:> 1000
Networking Rank (Reputation):> 1000

Ranking timeline:

Project Participation Performance(2015-01-01 - 2022-12-31 ):

Total Project Funding:

Funding per Partner:

Projects:

Leadership:

Total number of projects: 22
As coordinator: 2
As participant: 13
Sole participant: 7
Coordinator / Participant Ratio: 0.15*

Summary:

Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2022 150.000 6.298.591 493.648 1 2
2021 245.732 7.843.299 747.542 1 2
2020 172.932 1.874.996 187.409 1 1
2019 4.154.389 6.681.934 4.907.104 3 2
2018 2.499.980 3.407.194 2.747.853 1 1
2017 0 17.297.100 1.902.236 2
2016 257.191 3.818.970 505.064 1 1
2015 158.122 6.677.039 653.868 1 2

Networking:

Partners:

Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE4
UNIVERSITAIR MEDISCH CENTRUM UTRECHT3
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM2
GLYCOUNIVERSE GMBH & CO KOMMANDITGESELLSCHAFT AUF AKTIEN2
INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE2
JOHANN WOLFGANG GOETHE UNIVERSITAET FRANKFURT2
NATIONAL INSTITUTE OF CHEMISTRY2
NOVO NORDISK2
STICHTING RADBOUD UNIVERSITEIT2
STICHTING VUMC2
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD2
THE UNIVERSITY OF NOTTINGHAM2
UNIVERSITA DEGLI STUDI DI MILANO2
UNIVERSITA DEGLI STUDI DI MILANO BICOCCA2
UNIVERSITY OF BIRMINGHAM2
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM1
AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS1
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
ALLERGAN LIMITED1
ALTA RICERCA E SVILUPPO IN BIOTECNOLOGIE SRL ALTA1
ANAXOMICS BIOTECH S L1
ANTAROS MEDICAL AB1
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOMATERIALES1
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS1
ASTRAZENECA AB1
ATLAS MOLECULAR PHARMA SL1
AUSTRIAN RESEARCH CENTERS SIEBERDORF1
BASQUE BIOBANK FOR RESEARCH1
BASQUE COUNTRY UNIVERSITY1
BOEHRINGER INGELHEIM ANIMAL HEALTH FRANCE1
BOEHRINGER INGELHEIM PHARMA GMBH &CO KG1
BRISTOLMYERS SQUIBB COMPANY CORP1
BRUKER BIOSPIN1
CENTRE DE COOPERATION INTERNATIONALE EN RECHERCHE AGRONOMIQUE POUR LE DEVELOPPEMENT1
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS1
CONSIGLIO NAZIONALE DELLE RICERCHE1
CONSORZIO INTERUNIVERSITARIO RISONANZE MAGNETICHE DI METALLOPROTEINE PARAMAGNETICHE1
DIOMUNE SL1
DIVERCHIM1
ECHOSENS1
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE1
ELI LILLY AND COMPANY LIMITED1
ELLEGAARD GOTTINGEN MINIPIGS AS1
EOTVOS LORAND TUDOMANYEGYETEM1
ETHNIKO KAI KAPODISTRIAKO PANEPISTIMIO ATHINON1
EUROPEAN ASSOCIATION FOR THE STUDYOF THE LIVER1
EXALENZ BIOSCIENCE1
FACULDADE DE FARMACIA DA UNIVERSIDADE DE LISBOA1
FACULDADE DE MEDICINA DA UNIVERSIDADE DE LISBOA1
FRIEDRICH LOEFFLER INSTITUT BUNDESFORSCHUNGSINSTITUT FUER TIERGESUNDHEIT1
FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH FONDATION1
FUNDACIO INSTITUT DE RECERCA CONTRA LA LEUCEMIA JOSEP CARRERAS1
FUNDACION CENTRO NACIONAL DE INVESTIGACIONES ONCOLOGICAS CARLOS III1
FUNDACION PARA LA INVESTIGACION BIOMEDICA DEL HOSPITAL UNIVERSITARIO CLINICO SAN CARLOS1
GENFIT1
GENOMESCAN BV1
GILEAD SCIENCES INC1
GIOTTO BIOTECH1
GLAXOSMITHKLINE VACCINES1
GOETEBORGS UNIVERSITET1
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT1
HEIDELBERG UNIVERSITY HOSPITAL1
HISTOINDEX PTE1
HOSPITAL DU 12 OCTOBRE1
HYBRIGENICS1
ICENI DIAGNOSTICS LIMITED1
IMMUNXPERTS1
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE1
INNOVATIVE DIAGNOSTICS1
INST CARDIOMETABOLISME NUTRITION ICAN1
INSTITUT FUR MOLEKULARE BIOLOGIE GGMBH1
INSTITUT SENEGALAIS DE RECHERCHES AGRICOLES1
INSTITUTO DE MEDICINA MOLECULAR JOAO LOBO ANTUNES1
INTELLIGENT PHARMA SLU1
INTERCEPT PHARMA EUROPE1
IXSCIENT LIMITED1
JOHANNES KEPLER UNIVERSITAT LINZ1
KITHER BIOTECH1
LABSTRACT1
LATVIAN INSTITUTE OF ORGANIC SYNTHESIS1
LEIDS UNIVERSITAIR MEDISCH CENTRUM1
LINKOPINGS UNIVERSITET1
LIONEX1
LOFARMA1
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN1
LUDWIGMAXIMILIANSUNIVERSITAET MUENCHEN1
LUXEMBOURG INSTITUTE OF HEALTH1
MASARYKOVA UNIVERZITA1
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV1
MAXPLANCKGESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV1
MEDIZINISCHE UNIVERSITAET WIEN1
MERCK KOMMANDITGESELLSCHAFT AUF AKTIEN1
MINISTERIO DE AGRICULTURA PESCA Y ALIMENTACION1
MRC TECHNOLOGY1
NANTES UNIVERSITE1
NORDIC BIOSCIENCE1
NORDIC BIOSCIENCE COMPOUND DEVELOPMENT1
NOVA MEDICAL SCHOOL1
NOVARTIS1
NOVARTIS PHARMA1

Constancy:

Total number of partners: 190
Partner loyalty:
Frequent Partner: (> 2 projects): 7
Rare Partner: 183
Frequent / Rare Partner Ratio: 0.04

Project overview:

Start dateProjectacronymrolefundingpartners
2022-07-01Remote NMR (R-NMR): Moving NMR infrastructures to remote access capabilities R-NMRparticipant1.350.00026
2022-07-01Improved control of priority animal diseases: Novel vaccines and companion diagnostic tests for African horse sickness, peste des petits ruminants and foot-and-mouth disease SPIDVACparticipant4.948.59113
2022-06-01Development of a first-in-class inhibitor of FIH for cancer immunotherapy FIH-IOcoordinator150.0001
2021-10-29Probing CD28 as checkpoint for T cell co-stimulation in cancer and infection CD28coordinator245.7322
2021-07-01PI3K/PTEN-related monogenic disease to understand cancer PIPgenparticipant4.099.07511
2021-03-01A multidisciplinary training network for the bioinspired development of glycomimetics tuning the Siglec-Sialoglycan axis GLYTUNESparticipant3.744.22411
2020-10-01Deconstructing the Translational Control of Myelination by Specialized Ribosomes MyeRIBOparticipant1.874.9962
2020-03-01Target identification and elucidation of the molecular mechanism of action of saponin vaccine adjuvants QS-21 (QS21Mech) QS21-Mechcoordinator172.9321
2019-11-01Targeting the adaptive capacity of prostate cancer through the manipulation of transcriptional and metabolic traits CancerADAPTcoordinator1.999.8821
2019-10-01The life cycle of extracellular vesicles in prostate cancer: from biogenesis and homing, to functional relevance proEVLifeCycleparticipant2.672.56210
2019-10-01anti-Bacterial Innovative Vaccine Training Network. BactiVaxparticipant4.009.37312
2019-04-16Chemoenzymatic glyco-engineering of therapeutic monoclonal antibodies GlycoMabscoordinator160.9321
2019-02-01Exploiting the hypoxia response in T cells for Next-Generation Immuno-Oncology NextGen IOcoordinator1.993.5751
2018-09-01Breaking the limits in glycan recognition by NMR RECGLYCANMRcoordinator2.499.9801
2018-01-01European Research Training to Decipher The Ub Code : identification of potential biomarkers and drug targets UbiCODEparticipant3.407.19420
2017-11-01Liver Investigation: Testing Marker Utility in Steatohepatitis LITMUSparticipant15.797.88156
2017-03-01Elucidating the Molecular Mechanisms of Synthetic Saponin Adjuvants and Development of Novel Self-Adjuvanting Vaccines ADJUV-ANT VACCINESparticipant1.499.2191
2016-09-01Tribbles Research and Innovation Network TRAINparticipant3.818.97017
2016-07-05First Chemoselective Synthesis and Structural Studies of Lasso Peptides FCSSSLPcoordinator257.1912
2015-11-01A training network for the rational design of the next generation of well-defined glycoconjugate vaccines GLYCOVAXparticipant3.554.50012
2015-04-01Cholesterol metabolism as a driver of prostate cancer aggressiveness ACMcoordinator158.1221
2015-01-01Toll-Like Receptor 4 activation and function in diseases: an integrated chemical-biology approach. TOLLerantparticipant3.122.53910